OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing maduramicin as a novel anticancer and anti-metastasis agent for triple-negative breast cancer as enhanced by nanoemulsion
Xinhao Song, Yan Zhang, Runan Zuo, et al.
International Journal of Pharmaceutics (2022) Vol. 625, pp. 122091-122091
Closed Access | Times Cited: 7
Xinhao Song, Yan Zhang, Runan Zuo, et al.
International Journal of Pharmaceutics (2022) Vol. 625, pp. 122091-122091
Closed Access | Times Cited: 7
Showing 7 citing articles:
Drug Repurposing in Cancer Therapy
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 4
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 4
A comprehensive review on nanocarriers as a targeted delivery system for the treatment of breast cancer
Amreen Fatima, Nazish Naseem, Md. Faheem Haider, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 3, pp. 415-426
Open Access | Times Cited: 3
Amreen Fatima, Nazish Naseem, Md. Faheem Haider, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 3, pp. 415-426
Open Access | Times Cited: 3
Repurposing Polyether Ionophores as a New-Class of Anti-SARS-Cov-2 Agents as Adjunct Therapy
Keerthana Gurukkalot, Vinoth Rajendran
Current Microbiology (2023) Vol. 80, Iss. 8
Closed Access | Times Cited: 5
Keerthana Gurukkalot, Vinoth Rajendran
Current Microbiology (2023) Vol. 80, Iss. 8
Closed Access | Times Cited: 5
Nanoemulsion potentiates the anti-cancer activity of Myricetin by effective inhibition of PI3K/AKT/mTOR pathway in triple-negative breast cancer cells
Preeti Sharma, Shubhra Chaturvedi, Mohammad Ahmed Khan, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 1
Preeti Sharma, Shubhra Chaturvedi, Mohammad Ahmed Khan, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 1
Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors
Xinhao Song, Mengjuan Lin, Fang Tian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116062-116062
Open Access | Times Cited: 3
Xinhao Song, Mengjuan Lin, Fang Tian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116062-116062
Open Access | Times Cited: 3
The highly hazardous veterinary drug “maduramicin” and its toxicokinetics in rats
Bowen Cheng, Huarui Zhang, Zhao Wen-jin, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39620-e39620
Open Access
Bowen Cheng, Huarui Zhang, Zhao Wen-jin, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39620-e39620
Open Access
Nanocarriers for delivering nucleic acids and chemotherapeutic agents as combinational approach: Challenges, clinical progress, and unmet needs
Mahfoozur Rahman, Obaid Afzal, Shehla Nasar Mir Najib Ullah, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105326-105326
Closed Access | Times Cited: 1
Mahfoozur Rahman, Obaid Afzal, Shehla Nasar Mir Najib Ullah, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105326-105326
Closed Access | Times Cited: 1
